中文

泰格医药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥1.80B+15.2%
Gross profit¥0.48B
Operating income¥0.41B
Net income¥0.33B+200.1%
Gross margin26.6%Net margin 18.3%
Revenue Q/Q-0.3%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥1.32B73.4%
R&D¥0.06B3.5%
SG&A¥0.23B12.7%
Tax & other¥0.08B4.2%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

长亮科技金卡智能华鹏飞永贵电器ST信源东土科技东华测试蒙草生态我武生物楚天科技全通教育炬华科技

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies